Breakthrough sleep apnea medication AD109 shows promising results in phase 3 trials, potentially helping 30 million Americans with the condition.

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.

Strategists Alice Stewart and Bill Press join us to talk about the latest political news. And, NPR's Domenico Montanaro joins us to talk about the new NPR/PBS NewsHour/Marist poll that found ...

Air Voel is shining a spotlight on the latest generation of sleep apnea therapy with the AirSense 11 CPAP machines, a ...

It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

CHARLOTTE — Be honest: Do you snore? Does your partner say you snore? Snoring is disruptive and, in some severe cases, even life-threatening. An overnight sleep test can detect whether you have ...

WASHINGTONWASHINGTON — The company responsible for a global recall of sleep apnea machines will be barred from resuming production at U.S. facilities until it meets a number of safety requirements, ...

Snoring affects more than 37 million adults in the U.S. While often harmless, it can disrupt sleep and signal underlying health issues. A top sleep expert shares what really helps — and which popular ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — The company responsible ...